the bioenergetic differences among HIV-infected women related to the direct mitotoxic effects of ART? Indeed, it has been reported that peripheral blood mononuclear cells from HIV-infected patients on ART exhibit reduced mitochondrial membrane potential [35] . Future studies can address whether changes in body composition occur in parallel with mitochondrial alterations in this patient population, or if there a causal relationship. A possible interpretation of the reported results may be that systemic bioenergetic capacity, as reported by blood-based bioenergetic profiling, is responding to changes in metabolic demand that occur as a result of alterations in body composition. A major implication of this work is that these questions, and numerous others, can be addressed by using the blood-based bioenergetic profiling approach being utilized by this research group and others. Such assays are minimally invasive and therefore amenable for use in longitudinal studies. Using these approaches, it is possible to track HIV infected individuals through the course of disease progression and the treatment with ART. This current study by Willig et al., and future research stemming from this work, may also have important clinical implications. The ability to track the mitotoxic effects of ART in individual patients can support the development of more optimized treatment strategies that are able to balance the treatment of HIV infection with potential side-effects related to systemic mitochondrial toxicity.
